Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Depreciation and Depletion (2022 - 2024)

Centessa Pharmaceuticals has reported Depreciation and Depletion over the past 3 years, most recently at $48000.0 for Q4 2024.

  • Quarterly Depreciation and Depletion fell 47.83% to $48000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2024, changed 0.0% year-over-year, with the annual reading at $300000.0 for FY2025, 0.0% changed from the prior year.
  • Depreciation and Depletion was $48000.0 for Q4 2024 at Centessa Pharmaceuticals, down from $82000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $92000.0 in Q4 2023 and troughed at $28000.0 in Q1 2022.
  • The 3-year median for Depreciation and Depletion is $65000.0 (2024), against an average of $60916.7.
  • Year-over-year, Depreciation and Depletion soared 162.5% in 2023 and then tumbled 47.83% in 2024.
  • A 3-year view of Depreciation and Depletion shows it stood at $36000.0 in 2022, then soared by 155.56% to $92000.0 in 2023, then tumbled by 47.83% to $48000.0 in 2024.
  • Per Business Quant, the three most recent readings for CNTA's Depreciation and Depletion are $48000.0 (Q4 2024), $82000.0 (Q3 2024), and $84000.0 (Q2 2024).